Details of the Drug

General Information of Drug (ID: DMC7B1B)

• Drug Name: BMS-986403

Indication

Disease Entry	ICD 11	Status	REF
Chronic lymphocytic leukaemia	2A82.0	Phase 1	[1]

• Cross-matching ID: TTD ID: D3SP2U

References

• [1] ClinicalTrials.gov (NCT05244070) A Phase 1, Multicenter, Open-label Study of BMS-986403 in Subjects With Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL). U.S.National Institutes of Health.